Статті в журналах з теми "Antineoplastic agents Safety measures"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Antineoplastic agents Safety measures".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Griggs, Jennifer J., Kari Bohlke, Edward P. Balaban, James J. Dignam, Evan T. Hall, R. Donald Harvey, Diane P. Hecht, et al. "Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update." Journal of Clinical Oncology 39, no. 18 (June 20, 2021): 2037–48. http://dx.doi.org/10.1200/jco.21.00471.
Повний текст джерелаSilva, Trajano Felipe Barrabas Xavier da, Humberto Costa, and Marcelo Montebello Ribeiro. "Chemical risks that nurses are exposed in antineoplastic therapy services in a hospital setting: a systematic review protocol." Scientific Electronic Archives 14, no. 3 (February 26, 2021): 112–15. http://dx.doi.org/10.36560/14320211304.
Повний текст джерелаBenhabib, Amine, Saïd Ioughlissen, Christelle Ratignier-Carbonneil, and Patrick Maison. "The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study." BMJ Open 10, no. 3 (March 2020): e034033. http://dx.doi.org/10.1136/bmjopen-2019-034033.
Повний текст джерелаHealy, Regan, Deborah Passey, Derek Pinnell, Joshua Qualls, Clayton Hamilton, Zach Burningham, Elizabeth Tilley, Tanya Hood, Brian C. Sauer, and Ahmad Sami Halwani. "Veterans on anticancer medications in rural and community environment support (VA CARES) program: A pharmacist-led telemedicine medication management program for veterans receiving oral antineoplastic therapies through the MISSION Act." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 1545. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.1545.
Повний текст джерелаGraeve, Catherine Utecht, Patricia Marie McGovern, Bruce Alexander, Timothy Church, Andrew Ryan, and Martha Polovich. "Occupational Exposure to Antineoplastic Agents." Workplace Health & Safety 65, no. 1 (October 7, 2016): 9–20. http://dx.doi.org/10.1177/2165079916662660.
Повний текст джерелаBrana, Irene, Geoffrey Shapiro, Melissa Lynne Johnson, Helena Alexandra Yu, Debbie Robbrecht, Daniel Shao-Weng Tan, Lillian L. Siu, et al. "Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 3005. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3005.
Повний текст джерелаSewell, Graham J. "Pharmaceutical issues: preparation and handling." Journal of Oncology Pharmacy Practice 1, no. 1_suppl (May 1995): 6–12. http://dx.doi.org/10.1177/1078155295001001s03.
Повний текст джерелаKruse, R. H., W. H. Puckett, and J. H. Richardson. "Biological safety cabinetry." Clinical Microbiology Reviews 4, no. 2 (April 1991): 207–41. http://dx.doi.org/10.1128/cmr.4.2.207.
Повний текст джерелаVucicevic, Jelica, Katarina Nikolic, and John B. O. Mitchell. "Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches." Current Medicinal Chemistry 26, no. 21 (September 19, 2019): 3874–89. http://dx.doi.org/10.2174/0929867324666170712115411.
Повний текст джерелаPassamonti, Francesco, Martin Griesshammer, Michele Cavo, Miklos Egyed, Giulia Benevolo, Timothy Devos, Jeannie Callum, et al. "Demographics, Baseline Characteristics, and Disease Symptom Burden in RESPONSE-2: A Randomized, Phase 3 Study of Ruxolitinib in Polycythemia Vera Patients (pts) Who Are Resistant to or Intolerant of Hydroxyurea (HU)." Blood 126, no. 23 (December 3, 2015): 2807. http://dx.doi.org/10.1182/blood.v126.23.2807.2807.
Повний текст джерелаLi, Edward C., Glen Schumock, and Samuel Hong. "Spending on antineoplastic agents in the United States: 2011-2016." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 6618. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.6618.
Повний текст джерелаEscudero-Vilaplana, Vicente, Jose Luis Revuelta-Herrero, Roberto Collado-Borrell, Belen Marzal-Alfaro, Alvaro Gimenez-Manzorro, Ana Herranz-Alonso, and María Sanjurjo-Saez. "Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice." Expert Opinion on Drug Safety 18, no. 9 (July 15, 2019): 861–68. http://dx.doi.org/10.1080/14740338.2019.1641197.
Повний текст джерелаSessink, Paul J. M., Barry C. J. Wittenhorst, Rob B. M. Anzion, and Rob P. Bos. "Exposure of Pharmacy Technicians to Antineoplastic Agents: Reevaluation after Additional Protective Measures." Archives of Environmental Health: An International Journal 52, no. 3 (May 1997): 240–44. http://dx.doi.org/10.1080/00039899709602893.
Повний текст джерелаVail, David M., Douglas H. Thamm, Daniel B. Tumas, Hans Reiser, Adrian S. Ray, Grushenka H. I. Wolfgang, Darius Babusis, et al. "GS-9219 - A Novel Prodrug of the Acyclic Nucleotide PMEG Demonstrates Significant Therapeutic Activity Against Spontaneous Non-Hodgkin’s Lymphoma as Modeled in Pet Dogs." Blood 110, no. 11 (November 16, 2007): 1380. http://dx.doi.org/10.1182/blood.v110.11.1380.1380.
Повний текст джерелаEscudero-Vilaplana, V., A. Ribed, R. M. Romero-Jimenez, A. Herranz-Alonso, and M. Sanjurjo-Saez. "Pharmacotherapy follow-up of key points in the safety of oral antineoplastic agents." European Journal of Cancer Care 26, no. 3 (February 12, 2016): e12463. http://dx.doi.org/10.1111/ecc.12463.
Повний текст джерелаKawasaki, Yoichi, Noriko Yokoyama, Naoyuki Matsuka, Michihiro Izushi, Rieko Kawashima, Takeo Okada, Toshiaki Sendo, and Yutaka Gomita. "Sterility Management for Preparation of Antineoplastic Agents in a Class II Biological Safety Cabinet." Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 32, no. 12 (2006): 1261–66. http://dx.doi.org/10.5649/jjphcs.32.1261.
Повний текст джерелаBadescu, Minerva Codruta, Oana Viola Badulescu, Dragos Viorel Scripcariu, Lăcrămioara Ionela Butnariu, Iris Bararu-Bojan, Diana Popescu, Manuela Ciocoiu, et al. "Myocardial Ischemia Related to Common Cancer Therapy—Prevention Insights." Life 12, no. 7 (July 12, 2022): 1034. http://dx.doi.org/10.3390/life12071034.
Повний текст джерелаArablinskiy, N. A., O. D. Ostroumova, and A. V. Filippova. "Antineoplastic agents associated with the development of drug-induced pancreatitis." Meditsinskiy sovet = Medical Council, no. 9 (August 7, 2021): 114–21. http://dx.doi.org/10.21518/2079-701x-2021-9-114-121.
Повний текст джерелаHu, Lang-Yue, Wen-Li Mi, Gen-Cheng Wu, Yan-Qing Wang, and Qi-Liang Mao-Ying. "Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms." Current Neuropharmacology 17, no. 2 (January 7, 2019): 184–96. http://dx.doi.org/10.2174/1570159x15666170915143217.
Повний текст джерелаSzwamel, Katarzyna, Żaneta Dębicka, and Marta Gawlik. "Antineoplastic agents and the use of personal protective equipment: nursing staff awareness." Medical Science Pulse 13, no. 4 (March 31, 2020): 1–20. http://dx.doi.org/10.5604/01.3001.0014.1208.
Повний текст джерелаMescherina, Natalia S., Tatiana S. Mikhailenko, Elena M. Khardikova, Igor A. Sarayev, and Tatiana S. Leontieva. "Cardiovascular toxicity induced by chemotherapy and target drugs: mechanisms, diagnostic and preventive approaches." Человек и его здоровье 24, no. 4 (2021): 24–33. http://dx.doi.org/10.21626/vestnik/2021-4/04.
Повний текст джерелаCrul, M., and K. Simons-Sanders. "Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies." Journal of Oncology Pharmacy Practice 24, no. 7 (April 28, 2017): 483–89. http://dx.doi.org/10.1177/1078155217704990.
Повний текст джерела강민경, 이연주, 김다진, 김재연, 여미진, 이연홍, 문진영, 허영설, 박향민, and 이윤선. "Survey of Work Environment and Healthcare Workers Safety for Handling Antineoplastic Agents in Korean Hospitals." Journal of Korean Society of Health-System Pharmacists 32, no. 2 (May 2015): 104–18. http://dx.doi.org/10.32429/jkshp.2015.32.2.002.
Повний текст джерелаNoseda, Roberta, Laura Müller, Francesca Bedussi, Michele Fusaroli, Emanuel Raschi, and Alessandro Ceschi. "Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System." Cancers 15, no. 1 (December 28, 2022): 173. http://dx.doi.org/10.3390/cancers15010173.
Повний текст джерелаGidwani, Bina, and Amber Vyas. "A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs." BioMed Research International 2015 (2015): 1–15. http://dx.doi.org/10.1155/2015/198268.
Повний текст джерелаMugala, Prabhavathy. "In Vitro Cell Culture Drug Resistance Testing." Mapana - Journal of Sciences 2, no. 2 (June 17, 2004): 69–75. http://dx.doi.org/10.12723/mjs.4.8.
Повний текст джерелаMachado-Alba, Jorge Enrique, Anyi Liliana Jiménez-Morales, Yulieth Carolina Moran-Yela, Ilsa Yadira Parrado-Fajardo, and Luis Fernando Valladales-Restrepo. "Adverse drug reactions associated with the use of biological agents." PLOS ONE 15, no. 12 (December 18, 2020): e0240276. http://dx.doi.org/10.1371/journal.pone.0240276.
Повний текст джерелаBeg, Usman, Brianna Snyder, Sarosh Madhani, Nima Hamidi, and Alireza Mansouri. "RADT-46. SYSTEMATIC REVIEW OF RADIOSENSITIZERS FOR MALIGNANT BRAIN TUMORS: POTENTIAL FOR LEARNING FROM PAST FAILURES." Neuro-Oncology 22, Supplement_2 (November 2020): ii191. http://dx.doi.org/10.1093/neuonc/noaa215.799.
Повний текст джерелаLee, Euipyeong. "Analysis of the Problems and Safety Measures of Magnesium Fires." Journal of the Korean Society of Hazard Mitigation 20, no. 2 (April 30, 2020): 95–104. http://dx.doi.org/10.9798/kosham.2020.20.2.95.
Повний текст джерелаPisani, Silvia, Giulia Bertino, Adriele Prina-Mello, Laura Deborah Locati, Simone Mauramati, Ida Genta, Rossella Dorati, Bice Conti, and Marco Benazzo. "Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination." Cancers 14, no. 21 (October 31, 2022): 5363. http://dx.doi.org/10.3390/cancers14215363.
Повний текст джерелаMaluf, Sharbel Weidner, and Bernardo Erdtmann. "Evaluation of occupational genotoxic risk in a Brazilian hospital." Genetics and Molecular Biology 23, no. 2 (June 2000): 485–88. http://dx.doi.org/10.1590/s1415-47572000000200040.
Повний текст джерелаRoger, Inés, Paula Montero, Antonio García, Javier Milara, Pilar Ribera, Jose Alejandro Pérez-Fidalgo, and Julio Cortijo. "Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro." Pharmaceuticals 15, no. 9 (September 6, 2022): 1111. http://dx.doi.org/10.3390/ph15091111.
Повний текст джерелаAziz, Khalid, Hafiza Sayyar, and Ambreen Shahzad. "Precautions and Safety Measures at Workplace During Pandemic." Journal of Bahria University Medical and Dental College 10, no. 4 (October 1, 2020): 327. http://dx.doi.org/10.51985/jbumdc2020047.
Повний текст джерелаO'Shaughnessy, J. A., R. E. Wittes, G. Burke, M. A. Friedman, J. R. Johnson, J. E. Niederhuber, M. L. Rothenberg, J. Woodcock, B. A. Chabner, and R. Temple. "Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials." Journal of Clinical Oncology 9, no. 12 (December 1991): 2225–32. http://dx.doi.org/10.1200/jco.1991.9.12.2225.
Повний текст джерелаPark, Seon-Ja, and Hyun-Ju Kim. "Nurses’ Compliance with Safety Guidelines for the Use of Antineoplastic Agents, Observable Symptoms, and Stress from Occupational Exposure." Journal of Korean Academy of Fundamentals of Nursing 25, no. 4 (November 30, 2018): 293–300. http://dx.doi.org/10.7739/jkafn.2018.25.4.293.
Повний текст джерелаYun, Ji Hyun, and Jeong Yun Park. "Oncology Nurses' Knowledge of Safety Guidelines and Compliance with Safe Handling of Antineoplastic Agents in a Tertiary Hospitall." Asian Oncology Nursing 16, no. 4 (2016): 251. http://dx.doi.org/10.5388/aon.2016.16.4.251.
Повний текст джерелаRibed, Almudena, Vicente Escudero-Vilaplana, Rosa Maria Romero-Jimenez, Irene Iglesias-Peinado, Ana Herranz-Alonso, and Maria Sanjurjo-Saez. "Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents." Expert Opinion on Drug Safety 15, no. 4 (March 9, 2016): 427–35. http://dx.doi.org/10.1517/14740338.2016.1150998.
Повний текст джерелаFawzy, Nehmedo G., Siva S. Panda, Walid Fayad, May A. El-Manawaty, Aladdin M. Srour, and Adel S. Girgis. "Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies." Anti-Cancer Agents in Medicinal Chemistry 19, no. 8 (August 21, 2019): 1069–78. http://dx.doi.org/10.2174/1871520619666190408131639.
Повний текст джерелаSilva, Ana Elisa Bauer de Camargo, Adriano Max Moreira Reis, Adriana Inocenti Miasso, Jânia Oliveira Santos, and Silvia Helena De Bortoli Cassiani. "Adverse drug events in a sentinel hospital in the State of Goiás, Brazil." Revista Latino-Americana de Enfermagem 19, no. 2 (April 2011): 378–86. http://dx.doi.org/10.1590/s0104-11692011000200021.
Повний текст джерелаCollado-Borrell, Roberto, Vicente Escudero-Vilaplana, Almudena Ribed, Rosa Romero Jiménez, Irene Iglesias Peinado, Ana Herranz-Alonso, and María Sanjurjo-Sáez. "Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents." American Journal of Health-System Pharmacy 77, no. 17 (July 4, 2020): 1393–402. http://dx.doi.org/10.1093/ajhp/zxaa144.
Повний текст джерелаWhitley, Richard J. "The past as Prelude to the Future: History, Status, and Future of Antiviral Drugs." Annals of Pharmacotherapy 30, no. 9 (September 1996): 967–71. http://dx.doi.org/10.1177/106002809603000911.
Повний текст джерелаChiang, Shao-Chin, Mandy Shen, Chen-Chia Lin, and Hui-Ping Chang. "Establishing a protocol for the compatibilities of closed-system transfer devices with multiple chemotherapy drugs under simulated clinical conditions." PLOS ONE 16, no. 9 (September 28, 2021): e0257873. http://dx.doi.org/10.1371/journal.pone.0257873.
Повний текст джерелаSpano, Jean-Philippe, Dominique Costagliola, Christine Katlama, Nicolas Mounier, Eric Oksenhendler, and David Khayat. "AIDS-Related Malignancies: State of the Art and Therapeutic Challenges." Journal of Clinical Oncology 26, no. 29 (October 10, 2008): 4834–42. http://dx.doi.org/10.1200/jco.2008.16.8252.
Повний текст джерелаZhang, Shengqi, Chengsong Ye, Jianguo Li, Xin Yu, and Mingbao Feng. "Treatment-driven removal efficiency, product formation, and toxicity evolution of antineoplastic agents: Current status and implications for water safety assessment." Water Research 206 (November 2021): 117729. http://dx.doi.org/10.1016/j.watres.2021.117729.
Повний текст джерелаSamuel, N., and S. Verma. "Cross-comparison of cancer drug approvals at three international regulatory agencies." Current Oncology 23, no. 5 (October 26, 2016): 454. http://dx.doi.org/10.3747/co.23.2803.
Повний текст джерелаЗемский, Геннадий Тимофеевич, Леонид Петрович Вогман, and Наталья Валентиновна Кондратюк. "FIRE SAFETY OF HEAT-TRANSFER AGENTS FOR HEAT GENERATORS." Актуальные вопросы пожарной безопасности, no. 3(9) (September 1, 2021): 11–21. http://dx.doi.org/10.37657/vniipo.avpb.2021.31.82.002.
Повний текст джерелаKahangi, Leila Sadat, and Narges Toghian Chaharsoughi. "Chemotherapy medication errors in patients with cancer: A narrative review." Journal of Multidisciplinary Care 10, no. 3 (September 30, 2021): 126–31. http://dx.doi.org/10.34172/jmdc.2021.25.
Повний текст джерелаPatyashina, M. A., M. V. Trofimova, L. G. Avdonina, L. T. Garaeva, and G. R. Mansurova. "Provision of Biological Safety in the Territory of the Republic of Tatarstan during Preparation and Holding of FIFA World Cup-2018 in Kazan." Problems of Particularly Dangerous Infections, no. 1 (April 3, 2019): 113–17. http://dx.doi.org/10.21055/0370-1069-2019-1-113-117.
Повний текст джерелаPark, Soo Been, Mira Moon, Hyun Hwa Kim, Ga-Yoon Park, Dong Yoon Kang, Ju-Yeun Lee, Yoon Sook Cho, Hye-Ryun Kang, and Sang-Heon Cho. "A 10-Year Single-Center Experience of Adverse Drug Reaction Monitoring." Korean Journal of Medicine 96, no. 4 (August 1, 2021): 341–51. http://dx.doi.org/10.3904/kjm.2021.96.4.341.
Повний текст джерелаEzaki, Asami, Akihiro Hirakawa, Hideki Hanaoka, and Yoshiaki Uyama. "Factors Influencing Classifications of Safety Specifications in a Risk Management Plan for Antineoplastic Agents Approved in Japan: A Review and Descriptive Analysis." Therapeutic Innovation & Regulatory Science 55, no. 5 (June 9, 2021): 1075–81. http://dx.doi.org/10.1007/s43441-021-00309-5.
Повний текст джерела